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Cardiotoxic drugsThe human ether-a-go-go-related gene (hERG) voltage-gated K+ channels are located in heart cell mem-
branes and hold a unique selectivity ﬁlter (SF) amino acid sequence (SVGFG) as compared to other K+ chan-
nels (TVGYG). The hERG provokes the acquired long QT syndrome (ALQTS) when blocked, as a side effect of
drugs, leading to arrhythmia or heart failure. Its pore domain – including the SF – is believed to be a
cardiotoxic drug target. In this study combining solution and solid-state NMR experiments we examine the
structure and function of hERG's L622-K638 segment which comprises the SF, as well as its role in the ALQTS
using reported active drugs. We ﬁrst show that the SF segment is unstructured in solution with and without
K+ ions in its surroundings, consistent with the expected ﬂexibility required for the change between the dif-
ferent channel conductive states predicted by computational studies. We also show that the SF segment has
the potential to perturb the membrane, but that the presence of K+ ions cancels this interaction. The SF moi-
ety appears to be a possible target for promethazine in the ALQTS mechanism, but not as much for bepridil,
cetirizine, diphenhydramine and ﬂuvoxamine. The membrane afﬁnity of the SF is also affected by the pres-
ence of drugs which also perturb model DMPC-based membranes. These results thus suggest that the mem-
brane could play a role in the ALQTS by promoting the access to transmembrane or intracellular targets on
the hERG channel, or perturbing the lipid–protein synergy.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
The human ether-à-go-go-related-gene (hERG) channels are voltage-
gated potassium channels (KV) located in the myocardium cell mem-
branes and essential for heart function. The kinetics of the hERG function-
ing is atypical: it is characterized by slow activation and deactivation
processes, and fast voltage-dependant inactivation [1]. Undermembrane
depolarization, the channel slowly proceeds from a closed to an open
conformation to rapidly adopt an inactivated state that involves closing
of the channel's outer mouth. During heart repolarization, the hERG re-
opens for a longer time before closing again. A resurgent IKr current is
measured during this interval. If this K+ current is disrupted by muta-
tions or drugs, it prolongs the repolarization interval between Q and T
waves on the electrocardiogram, thus provoking arrhythmia or heart fail-
ure [1]. The acquired form of this long QT syndrome (ALQTS) is the most
common and occurs as a side effect of drugs when they generally block
hERG channels. ALQTS is the ﬁrst cause of delayed drug approval by the
FDA and is frequently responsible for drug withdrawal from the marketniversité duQuébec àMontréal,
da H3C 3P8. Tel.: +1 514 987
tte).
l rights reserved.despite mandatory in vitro testing of all new drug entities for hERG-
blocking potential [2,3].
The hERG channel is composed of four monomeric subunits, each
containing six transmembrane spanning helices (S1-S6). It has never
been crystallized and its structure is predicted by homology studies
with similar K+ channels, such as the bacterial KcsA [4], the drosophila
Shaker and the human Kv1.1 [5], aided by electrophysiological, in silico
and spectroscopic studies on hERG segments [6–12]. The ﬁrst four heli-
ces (S1–S4) compose the voltage sensor while S5 and S6 form the pore
domain. S5 is connected to S6 by an extracellular loop more than twice
the length of most K+ channels [9,13], followed by the small pore helix
and the K+-selective ﬁlter as illustrated in Fig. 1A. Interestingly, the se-
lectivity ﬁlter (SF) of the hERG channel adopts a unique signature of
Ser-Val-Gly-Phe-Gly as opposed to Thr-Val-Gly-Tyr-Gly for most potas-
sium channels [5].
Considering the hERG channel's unique SF sequence, reﬁning its
structural model would be essential in order to gain a better under-
standing of its function. In KV channels such as KcsA, the SF is thought
to expose carbonyl oxygen atoms to the extracellular solution to attract
K+ ions [14,15]. The ﬁlter would then adopt different conformations at
high and low K+ concentrations respectively corresponding to the con-
ductive and non-conductive states [14,16]. Molecular dynamics (MD)
studies and crystallographic X-ray structures support the SF's backbone
ﬂexibility at low K+ concentrations as local structural changes in the
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Fig. 1. A) Amino acid sequence and predicted topology of the hERG channel pore domain (S5–S6) [12,22]. The bold text indicates the L622-K638 segment synthesized for NMR anal-
ysis. B) 1H–1H contacts for hERG L622-K638 in water obtained by ROESY with a 300 ms mixing time. Bar widths are proportional to cross peak intensities. Unassigned protons are
marked with an asterisk.
Table 1
Partition coefﬁcients (log P), pharmacological classes and structures of studied LQTS-active
drugs.
Drug Log P Structure
Bepridil
(antiarrhythmic)
5.2
Cetirizine
(antihistamine)
2.8
Diphenhydramine
(antihistamine)
3.3
Promethazine
(antihistamine)
4.4
Fluvoxamine
(antidepressant)
3.2
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tion during ion movement [14,17–20]. The conformational changes of
the SF during the opening and closing of K+ channel is still a matter of
debate [20,21]. Therefore the ﬁrst objective of this study was to verify
conformation changes of the L622-K638 segment – which comprises
the SF – with and without the presence of K+ ions using standard
two-dimensional (2D) solution nuclear magnetic resonance (NMR) ex-
periments. According to sequence homology with other K+ channels
[12,22], this segment corresponds to the linker connecting the pore
helix to the S6 transmembrane helix (Fig. 1A). Considering the position
of the SF of K+ channels in cell membranes [15,16], we have also stud-
ied the interaction of hERG's L622-K638 segment with model phospho-
lipids membranes using solid-state NMR (SS-NMR) and saturation
transfer difference (STD) experiments. Studying peptides from
membrane proteins and channels using techniques such as circular
dichroism (CD), molecular dynamics (MD) and NMR is a useful and
commonly used strategy that provides invaluable structural informa-
tion on proteins that are not easily overexpressed and puriﬁed such as
the hERG mammalian channel. For example, its extracellular S5P and
intracellular S4–S5 [9,11,12,23–25] linkers have been studied to gain a
better insight into their structure and function, aswell as the paddle do-
mains of KV channels such as KVAP and HsapBK to cite a few [26]. The
L622-K638moiety terminating a particularly long and ﬂexible extracellu-
lar pore loop of the hERG is very well-suited for a segmental study [27].
According to previous studies, some channel blockers would exert
their activity by binding Thr623, Ser624 and Val625 located at the intra-
cellular base of the SF [28,29]. Therefore another goal of this work was
to investigate the role of the SF in the drug-induced blockade of hERG
leading to ALQTS. Five drugs with reported ALQTS activity were stud-
ied, each having different structures and belonging to various phar-
macological classes as listed in Table 1. Bepridil is an antiarrhythmic
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dramine, promethazine and cetirizine are antihistaminic H1-receptor
antagonists [32,33]. These four drugs have been suspected to block
the hERG channel, most often by interacting with binding sites
found in the hERG's pore cavity. However, ﬂuvoxamine, a selective-
serotonin re-uptake inhibitor often prescribed to treat depression,
does not appear to bind to this region. For some drugs, their large
size alone would suggest their unlikeliness to ﬁt in the pore cavity,
such as the antibiotic erythromycin [34]. The possibility of additional
binding sites on the cytoplasmic or extracellular side of the hERG
channel should thus be considered [34–36]. For that reason, we
have studied the potential binding of LQTS-active drugs to the SF
segment.
Finally, we have investigated the role of the membrane in the
ALQTS. Some drugs, such as promethazine, have a high afﬁnity for
membrane bilayers containing phosphatidylcholines (PCs) and can
potentially disrupt the lipid–protein synergy [36,37]. This perturba-
tion via non-speciﬁc hydrophobic and electrostatic interactions
could indirectly block the hERG channel function. Using translational
diffusion measurements, we have thus veriﬁed the afﬁnity of the se-
lected drugs for the model membranes. Additionally, the perturbation
of polar head groups and acyl chains of model membranes was probe
using 31P- and 2H-SS-NMR experiments, respectively. Coupled with
STD experiments, this work provides an insight into the drugs' loca-
tion with respect to themembrane and eventually on themembrane's
role in the ALQTS.
2. Materials and methods
2.1. Materials
The L622-K638 segment with sequence LTSVGFGNVSPNTNSEK com-
prising the hERG's SF was synthesized by GenScript Corporation
(Piscataway, NJ, USA) with >95% purity. Protonated and deuterated
dimyristoyl- and dihexanoylphosphatidylcholine (DMPC, DMPC-d54,
DHPC, DHPC-d22) were purchased from Avanti Polar Lipids (Alabaster,
AL, USA). Fluvoxamine maleate, promethazine hydrochloride and
deuterium-depletedwaterwere obtained from SigmaAldrich (Oakville,
ON, Canada), while deuterium oxide (D2O) was purchased from CDN
isotopes (Pointe-Claire, QC, Canada).
2.2. Sample preparation
Bicelles and multilamellar vesicles (MLVs) respectively used for
solution- and solid-state NMR experiments were prepared by mixing
freeze-dried DHPC and/or DMPC in an aqueous solution at pH 4.5,
then submitted to a series of freeze (liquid N2)/thaw (50 °C)/vortex
cycles. The L622-K638 segment was mixed with the model membranes
during their preparation and the peptide concentration was kept
between 2 and 5 mM. The lipid concentration was maintained well
above the critical micelle concentration (CMC). Solid-state NMR samples
were prepared with deuterium-depleted water using a lipid/peptide
(L/P) molar ratio of 100:1, a lipid/drug (L/D) molar ratio of 180:1
with an 80% (w/v) hydration. A hydration percentage of 88% (w/v)
was used for samples studied by solution NMR. 1H diffusion NMR ex-
periments were carried out in D2O while all other high-resolution
NMRexperimentswere performedusing 10%D2O inwater. Translational
diffusion and saturation transfer difference (STD) measurements were
carried out using DMPC/DHPC (q)molar ratios of 0.5 and 1, respectively.
L/P molar ratios of 50:1 and 125:1 as well as an L/D molar ratio of 125:1
were employed.
2.3. Solution and solid-state NMR
All translational diffusion and STD experiments as well as TOCSY
spectra and solid-state NMR experiments were recorded on a hybridsolution/solid-state Varian Inova Unity 600 (Agilent, Santa Clara, CA,
USA) spectrometer operating at frequencies of 599.95 MHz for 1H,
246.86 MHz for 31P and 92.125 MHz for 2H. A double-resonance
3-mm indirect z-gradient probe was used in the solution mode
while a 4-mm broadband/1H dual-frequency magic-angle-spinning
probe head was employed for experiments on the solid state.
The 1H chemical shifts were internally referenced by adding 0.5 mM
of 2,2-dimethyl-2-silapentane-5-sulfonic acid (DSS) set to 0.0 ppm.
All 31P NMR spectra were externally referenced with respect to the
signal of 85% phosphoric acid set to 0 ppm.
ROESY spectra were recorded on a solution-state Bruker SB Ad-
vance DRX-400 (Bruker, Wissembourg, France) spectrometer operat-
ing at a 400.13 MHz for 1H using a 5 mm probe. 1H/13C heteronuclear
single-quantum correlation (HSQC) spectra were recorded at the
Québec/Eastern Canada High Field NMR Facility on a Varian Inova
500 spectrometer operating at frequencies of 499.72 MHz for 1H
and 125.64 MHz for 13C and equipped with a high-sensitivity 5-mm
cold probe.
2.3.1. Translational diffusion experiments
1H NMR self-diffusion measurements were carried out at 25 °C
using the bipolar LED stimulated echo sequence [38]. A hard 90°
pulse of 3.6 μs was used. The gradient pulse duration δ and diffusion
time Δ were varied between 2–3 ms and 100–150 ms, respectively,
to ensure that the echo intensities were attenuated by at least 80%.
20k data points were obtained and typically 16 scans were acquired
for each selected gradient strength with a recycle delay of 2 s. A com-
plete attenuation curve was obtained by measuring 25 gradient
strengths linearly incremented between 2.1 and 52.5 G/cm.
Translational diffusion coefﬁcients (DS) were calculated using the
following equation [39]:
S Gð Þ ¼ S 0ð Þ exp − γδGð Þ2 Δ−δ=3ð ÞDS
h i
ð1Þ
where S(G) is the echo amplitude and γ is the 1H gyromagnetic ratio.
The gradient strength was calibrated using back calculation of the coil
constant from the measurement of the diffusion constant of H2O
traces in D2O using DS = 1.9 × 10−5 cm2/s at 25 °C. The percentage
of SF or drug bound to the bicelles was calculated using the following
equation [40]:
% ¼ Dobs−Dϕfree
 
= Dbound−D
ϕ
free
 h i
 100 ð2Þ
where Dobs is the diffusion coefﬁcient of the bicelle-associated pep-
tide or drug, Dbound is the diffusion coefﬁcient of the bicelles in
water, and Dϕfree is the corrected diffusion coefﬁcient of the peptide
or drug in water where an obstruction factor (A) was introduced:
A ¼ 1= 1−0:5ϕð Þ ð3Þ
and
Dϕfree ¼ Dfree⋅A ð4Þ
where ϕ is the volume fraction of the obstructing particles, leading to
an obstruction factor of 0.938 for spheroid objects, as detailed in pre-
vious work [11]. In the case of drugs binding to SF, the obstruction
factor was not necessary, and Dobs refers to SF-associated drug, Dbound
to the diffusion coefﬁcient of the SF and Dfree to that of the drug in
water. Diffusion coefﬁcients were obtained by selecting 2 to 3 reso-
nances on the spectra and experiments were repeated between 2 to
4 times.
2.3.2. Saturation transfer difference (STD)
The STD experiments consisted of a train of 50 ms Gaussian selec-
tive pulses separated by 0.1 ms delays and followed by a WET water
PPM
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Fig. 2. 1H NMR spectra of the side chain region (top), amide and aromatic region
(bottom) of SF (2 mM) in 10% D2O (black solid line), and with DMPC-d54/DHPC
(q = 0.5) bicelles (grey dashed line) at a lipid/peptide ratio of 50:1.
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alternated between the resonance to be saturated and −25 ppm.
The resonances of the following DMPC groups have been saturated:
N(CH3)3 (3.25 ppm), glycerol (4.03) and acyl chain terminal methyl
(0.84 ppm). Gaussian pulses were applied with a radio-frequency
ﬁeld strength of 120 Hz and saturation times were varied between
250 ms and 5 s. The recycle delay was 4 s. Aromatic and amide pro-
tons were probed to avoid lipid resonance overlap. The resonances
of protons giving the most intense STD curve were selected and all
experiments done in duplicates.
2.3.3. High-resolution 1H two-dimensional experiments
1H total correlation spectroscopy (TOCSY) spectra were recorded
on a 600 MHz Varian spectrometer using a 90° pulse of 5.5 ms,
spin-lock times of 25, 100 and 250 ms with MLEV17 spin-lock ﬁelds
of 15 kHz [42]. A spectral width of 8 kHz was used in both dimen-
sions with 1024 and 512 complex data points in the direct and indi-
rect dimensions, respectively. 8 transients were accumulated with a
repetition delay of 0.5 s. 2D rotating frame Overhauser spectroscopy
(ROESY) spectra were recorded using a pulse length of 12 ms with
mixing times of varying from 100 to 300 ms. A spectral width of
4.8 kHz was used in both dimensions with 2048 data points in F2
and 512 increments in F1. 16 scans were recorded with a repetition
delay of 2 s. HSQC spectra were recorded using a 1H 90° pulse ranging
from 6.4 to 8.5 ms and a 13C 90° pulse of 15.6 ms. A 8 kHz spectral
width in F1 and F2 was used with 1024 data points in F2 and 200 in-
crements in F1. 4 transients were accumulated with a repetition delay
of 1.2 s.
2.3.4. Solid-state NMR (SS-NMR) experiments
31P NMR spectra were recorded using a phase-cycled Hahn echo
pulse sequence with gated broadband proton continuous wave
decoupling at a ﬁeld strength of 50 kHz [43]. The interpulse delays
were 33 μs and typically 1024 scans were acquired with a recycle
delay of 5 s. The acquisition time was set at 10 ms with a 5 μs dwell
time. 2H NMR spectra were obtained using a solid echo pulse se-
quence [44] with interpulse delays of 20 μs and repetition delays of
0.5 s. This recycle delay was voluntarily set shorter than 5 times the
longest relaxation time in a saturated fatty acyl chain (300 ms) to op-
timize the total acquisition sequence. This procedure does not affect
the quadrupolar doublet positions that are extracted from the Pake
patterns. At least 5000 data points were obtained and typically 5000
scans were recorded with an acquisition time of 5 ms and 1 μs
dwell time. For all 2H and 31P NMR experiments, the 90° pulse length
was varied between 2.8 and 3.4 μs.
2.3.5. Data processing
Diffusion, STD and SS-NMR data were processed using matNMR
[45]. High-resolution 2D NMR spectra were processed using the
NMRPipe package [46] and analyzed with the software NMRView
for chemical shift assignment [47].
3. Results
3.1. Structure of the SF segment in aqueous environment
To better understand the structure–function relationship of the
hERG's SF, we have ﬁrst investigated its structure in water by solution
NMRwith andwithout K+ ions. So far, such studies of K+ channel selec-
tivity ﬁlters have targeted other KV channels and were performed
uniquely by molecular simulations [5,48–50]. We have used the syn-
thetic segment L622-K638 comprising the SF as illustrated in Fig. 1A.
About 95% of the chemical shifts of this SF segment were assigned
using TOCSY, ROESY and 1H-13C HSQC experiments (Fig. S1, Table S1).
As evidenced in Fig. 1B, no contacts indicative of a deﬁned secondary
structure were detected by 2D ROESY NMR experiments with mixingtimes up to 300 ms. Correspondingly no secondary structure was ob-
served by CD measurements (data not shown).
The effect of K+ ions on the SF's structure was then probed with
2D 1H TOCSY experiments. This was done by analyzing changes in
chemical shifts of the L622-K638 segment at high and low K+ concen-
trations selected to mimic the physiological intracellular (150 mM)
and extracellular (10 mM) concentrations of myocardial cells. No var-
iations in the proton resonances could be detected at both K+ con-
centrations. Because 13C nuclei are more sensitive to structural
modiﬁcations, 1H-13C HSQC correlation experiments were carried
out and no changes in chemical shift could be seen (data not shown).
3.2. Interaction of the SF segment with the membrane
Considering that the extracellular loop to which the hERG's SF seg-
ment is connected is long and highly ﬂexible, we have veriﬁed the
possible interaction of the L622-K638 segment with the membrane.
Since phosphatidylcholines (PCs) are the most abundant phospho-
lipids in cardiomyocyte membranes, i.e. 34–52% of total membrane
phospholipids [51], the model membranes employed for this study
were prepared with PC. The 1D 1H-NMR spectra of the SF segment
were recorded in water and in DMPC/DHPC bicelles, and comparison
of these spectra in Fig. 2 reveal changes in the chemical shifts of the
peptide's resonances. This suggests an interaction between this
hERG segment and the model membranes.
To further investigate this interaction, we have veriﬁed the afﬁnity
of the SF segment for the membrane environment using pulse ﬁeld
gradient (PFG) diffusion experiments. This technique allows measur-
ing translational diffusion coefﬁcients of the L622-K638 hERG segment,
drugs and PC bicelles in their free and bound states. If the SF segment
interacts with the drugs and/or model membranes, the resulting
diffusion coefﬁcient will be averaged from the bound and free state
(diffusion coefﬁcients displayed in Table S2). With these results, the
percentage of SF segment bound to drugs and/or bicelles can then
be estimated (Eq. (2)). As shown in Table 2, 48% of the SF segment
binds to model membranes at a lipid/peptide molar ratio of 100:1.
The addition of K+ ions at low concentrations slightly decreases the
SF segment's afﬁnity for the membrane (46%) while a high K+ con-
centration lowers it by almost half (28%).
The interaction of the SF segment with the model membranes was
further investigated by SS-NMR at physiological temperature using
MLVs made of DMPC with deuterated acyl chains. More speciﬁcally,
the perturbation of the phospholipid polar headgroups can be revealed
from the 31P spectra since the chemical shift anisotropy (CSA) of this
nucleus is sensitive to changes in orientation and dynamics [52]. The
apolar region of the bilayer was probed by studying the quadrupolar
splittings (ΔνQ) of the 2H nuclei on the acyl chains as the quadrupolar
Table 2
Calculated fraction of SF or drugs bound to the SF and to bicelles (with or without SF).
Values are calculated according to Eq. (2).
System Fraction of bound SF or drug (%)a
SF Bicelles SF/bicelles
SF – 48 –
Bepridil 9 100 100a (34)b
Cetirizine 14 100 100a (49)b
Diphenhydramine 8 96 96a (56)b
Fluvoxamine 3 100 100a (50)b
Promethazine 37 100 100a (66)b
SF/KCl (10 mM) – 46 –
SF/KCl (150 mM) – 28 –
a Fraction of drug bound to bicelles/SF samples.
b Fraction of SF bound to Bicelles/drug samples.
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presented in Fig. 3 without and with the SF segment are characteristic
of phospholipids in a lamellar phase with axial symmetry [52,53]. Com-
parison of spectra in Fig. 3A shows a slight disruption of the model
DMPC membranes when the SF segment is present. The phosphorus
CSA decreases from 45.3 to 39.5 ppm with the SF segment while no
changes in ΔνQ are observed in the 2H spectra. Consequently, the SF
segment would mainly interact with the membrane surface. Both 31P
and 2H SS-NMR spectra also display an isotropic peak in the presence
of the SF segment, indicative of the coexistence of vesicles and
rapidly-reorienting lipid structures, although the majority of the mem-
brane would remain intact [55]. Furthermore, when KCl is added at
low (10 mM, Fig. 3B) and high (150 mM, Fig. 3C) concentrations to
the SF/MLV samples, CSA and ΔνQ values of 31P and 2H spectra, respec-
tively, resemble those of a pure lipid system (DMPC MLV). Hence, the
effect of the SF segment on model membranes seems to be cancelled
when K+ ions are present. 31P and 2H SS-NMR spectra of DMPCwithout
and with KCl were recorded as controls and were superimposable
(not shown) as expected for K+ ions which have a weak effect on PC
headgroups [56–58].
To better understand the interaction of the SF segment with the
model membranes, STD experiments were conducted using DMPC/
DHPC bicelles (q = 1) by solution NMR. Mostly used to study theA
B
C
Frequency (kHz)
-40 -20 0 20 40
Chemical Shift (ppm)
-40-2002040
Fig. 3. Effect of the SF on the 31P (left) and 2H (right) SS-NMR spectra of DMPC MLVs,
with and without KCl, at 37 °C, with a lipid/SF molar ratio of 100:1. A) SF, B) SF with
10 mM KCl, C) SF with 150 mM KCl (dotted lines). The pure lipid spectra (solid line)
are overlayed for comparison.binding of ligands to protein, this technique can also help localizing
a molecule in the membrane when interacting with the lipids [41].
This is done by selectively saturating different lipid resonances, such
as the choline group at the bilayer surface, the glycerol group at the
polar/apolar interface, and the terminal methyl in the hydrophobic
core. The effect of this saturation on the saturation transfer build-up
of residues of the L622-K638 segment resonances can then help eluci-
dating its position with respect to the membrane as was shown
with amantadine [40], dynorphins [59] and the hERG's S5-P extracel-
lular linker [11]. Bicelles were made of DHPC with deuterated lipid
chains in order to probe the peptide penetration in the planar section
of the bilayer and minimize contacts with high-curvature regions.
Variations in the saturation transfer build up were monitored for
amide and aromatic protons of different residues along the peptide.
No transfers of saturation were observed on the protons of the SF
segment (data not shown) at a L/P molar ratio of 50:1. The absence of
STDs typically occurs if (1) all ligands are in the free state (not
bound); (2) the binding is too strong; (3) the ligands are somewhere
else in the membrane; (4) the dissociation of the ligands is slower
than the relaxation rate of the magnetization that is transferred; or
(5) if there is an excess of ligands obscuring the detection of the
ligands that are saturated as their concentration is too low in compar-
ison to the free ligands [41]. Because of the 48% association of the SF
determined by translational measurements, points 1 and 2 can be
ruled out. Point 3 is not likely as all regions of the phospholipids are
probed, i.e. the N(CH3)3 of the choline group, the glycerol and termi-
nal CH3 group of DMPC acyl chains. Therefore in order to verify Point
5, we have lowered the proportion of SF segment in the solution by
increasing the L/P ratio to 125:1. As can be seen in Fig. 4, weak STDs
could be detected with the choline headgroup exclusively for the ar-
omatic ring protons of Phe627 located in the SVGFG motif. This result
suggests that this residue is mainly responsible for the membrane
interaction.
3.3. Interaction of the SF segment with hERG-active drugs
Because the hERG's SF is a potential target for ALQTS-prone drugs,
we have investigated the interaction of cardiotoxic drugs with this
channel's segment. More speciﬁcally, bepridil, cetirizine, diphenhydra-
mine, ﬂuvoxamine and promethazine were selected. The association
of the drugs to the peptide was determined by translational diffusion
experiments. As shown in Table 2, out of all ﬁve drugs, promethazine
has the highest afﬁnity for the SF segment, 37% of which is binding to
it. Bepridil, cetirizine and diphenhydramine, on the other hand, demon-
strate a weaker afﬁnity for the SFwith 9, 14 and 8% binding, respective-
ly, whereas ﬂuvoxamine only shows a 3% association.
As a next step, we have veriﬁed the impact of the presence of
drugs on the afﬁnity of the SF segment for the membranes. The results
are compiled in Table 2. The data demonstrate that the presence of
some of the drugs promotes the peptide/membrane interaction by in-
creasing SF segment binding afﬁnity from 48% to 56% and 66% with
diphenhydramine and promethazine, respectively. Cetirizine and
ﬂuvoxamine have a negligible effect while bepridil decreases the SF
segment association by 14%.
3.4. Role of the membrane in the long QT syndrome
Since drugs responsible for ALQTS tend to have high log P values,
the potential drug–membrane interaction was investigated. All the
cardiotoxic drugs evaluated in this study have previously been
reported to have an afﬁnity for lipid membranes [11,60–62]. Hence,
the possibility of an indirect blockage of the hERG channel through
non-speciﬁc drug–membrane interactions cannot be ruled out. This
hypothesis was ﬁrst investigated using translational diffusion experi-
ments, as previously described. Table 2 shows that all drugs have a
high afﬁnity for the membrane, their association ranging between
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hydramine compare well with previously published data [11]. We
have also veriﬁed if the SF modiﬁes the association of the drugs to
the membranes, and Table 2 shows that their afﬁnity is unchanged.
Considering the high afﬁnity of the ﬁve cardiotoxic drugs for the PC
bicelles, their interaction with model membranes was probed using
SS-NMR experiments, as done with the SF. As shown in Fig. 5A, bepridil
has no effect on the 31P SS-NMR spectrum of the DMPC membranes.
The appearance of a small but measurable isotropic peak can be seen
in the 31P and 2H SS-NMR spectra when cetirizine (5B), diphenhydra-
mine (5C) and promethazine (5E) are added to DMPC MLVs at a lipid/
drug ratio of 180:1, indicating the formation of smaller vesicles. These
drugs as well as ﬂuvoxamine (5D) also have the effect of increasing
the 31P CSA, suggesting a reduced mobility of the phospholipid
headgroups. Moreover, these spectra show a change in intensity be-
tween the 0° and 90° edges, with less lipids on the 90° edge which
can be ascribed to a change in vesicle shape or transverse relaxation
(T2) effect caused by an increase in slow motions [63]. Analysis of the
2H SS-NMR spectra shows that cetirizine has little effect on the phos-
pholipid acyl chains, but a loss of resolution is seen for the quadrupolar
splittings of the plateau positions (C2-C8, close to the glycerol back-
bone)with the other drugs, andmore strikinglywith diphenhydramine.
Our results indicate that the LQTS-active drugs could either form
smaller objects or change the lipid diffusion rate [55,64].
To localize the ALQTS-active drugs within the membrane while
interacting with the bilayers, STD NMR experiments were carried
out, as was done with the SF, in q = 1 bicelles at a L/D molar ratio of
150:1. The effect of the saturation of the choline, glycerol and terminal
methyl of the lipids on the aromatic protons of the hERG-active drugs
is displayed in Fig. 4. Our data reveal that bepridil (4B) and
promethazine (4F) aromatic groups are in proximity of the glycerol
region of the membrane. Cetirizine (4C) and ﬂuvoxamine (4E), on
the other hand, show some interaction with the membrane surface,
more speciﬁcally with the choline headgroups. The saturation trans-
fers measured with diphenhydramine (4D) are remarkably low. Con-
sidering the 96% association of this drug to bicelles, its aromatic
protons would thus be too tightly bound for an STD signal to be
detected.4. Discussion
Homology studies have offered insightful predictions of hERG's
structure; however to better understand this channel's function and
role in the ALQTS, we must ﬁrst reﬁne its structural model by exper-
imental determination [4,5]. The use of peptides corresponding to
speciﬁc regions of membrane proteins and channels, as opposed to
full length proteins, is very helpful considering their difﬁcult expres-
sion and puriﬁcation. This is indeed particularly relevant for the noto-
riously long extracellular S5-S6 linker of the hERG channel for which
peptides representing the S5-P portion were studied by CD and solu-
tion NMR [9,11,12,23]. The TVGYG residues in the SF motif are highly
conserved amongst KV channels but the hERG channel has only
retained valine and glycine residues in its SF, leading to an SVGFG se-
quence. Seemingly, the glycine residues are indispensable for the
channel conformation where they offer the backbone ﬂexibility need-
ed when responding to the alternating outﬂow of K+ ions and water
molecules as shown with other KV channels [16]. Two steady states of
the SF have actually been documented for KcsA, i.e., a conductive and
a non-conductive one respectively existing at high and low K+ con-
centrations [14,16,20]. Although these conformations were seen on
a millisecond timescale in computational studies of the KcsA channel
and KirBac [20,65,66], they were not observed in our study for the
hERG channel's SF segment on the NMR timescale, in the absence
and presence of K+ ions. If the transition rate between conformations
is too fast, the resulting structure will be averaged. Thus, our 2D 1H
NMR results suggest that hERG's SF is unstructured in water. This is
in agreement with the ﬂexibility expected for a segment that must
be available for K+ binding, H-bonding with water molecules, and
which most likely spatially reorients during the channel functioning
[20,65,67]. According to MD studies on the KcsA [14,15], the hydra-
tion shell of K+ ions is partially removed in order to form electrostatic
interactions with the carbonyl oxygen atoms of the SF's TVGYG back-
bone. This eventual ion binding to the carbonyls is likely not to per-
turb sufﬁciently the 1H and 13C NMR signals, and we would thus be
unable to detect any changes.
Our solution and SS-NMR experiments have shown that the hERG's
SF segment has the potential to interact with the lipid membrane. This
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Fig. 5. Effect of LQTS-active drugs on the 31P (left) and 2H (right) SS-NMR spectra of
DMPC MLVs at 37 °C with a lipid/drug molar ratio of 180:1. A) bepridil, B) cetirizine,
C) diphenhydramine, D) ﬂuvoxamine and E) promethazine (dotted lines). The pure
lipid spectrum (solid line) is overlayed for comparison.
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added to isotropic bicelles (Fig. 2). The absence of peak broadening
indicates, however, that the SF segment remains free to tumble in the
bilayer and to diffuse laterally, as was observed by Wang et al. with
amantadine [40]. According to our diffusion experiments (Table 2),
hERG's L622-K638 segment has a 48% afﬁnity for PC membranes.
When “bound”, this amphiphilic peptide would prefer the bilayer sur-
face as only little effects are seen on the 2H SS-NMR spectrum using
DMPC-d54 vesicles (Fig. 3). This is supported by a change in the
headgroup dynamics suggested by the decrease in DMPC's CSA on the
31P spectrum in Fig. 3 and by the STD experiments which could only de-
tect saturation transfers between the N(CH3)3 of the choline headgroup
and the aromatic protons of the L622-K638 peptide. The formation of
fast-tumbling lipid assemblies could also be induced by the SF segment
as revealed by the isotropic resonance on the 31P and 2H spectra. Previ-
ous MD studies have shown interactions between the SF and the pore
helix [5]. The interaction between the SF segment and the membrane
could potentially be of similar nature and enabled by the ﬂexibility
imparted by the particularly long linker between S5 and the pore
helix (S5-P)which comprises 43 amino acid residues vs. 12–23 residues
in most K+ channels [9,27,36]. As revealed by 31P and 2H SS-NMR, theaddition of K+ ions at both intra- (150 mM) and extracellular
(10 mM) concentrations appear to cancel the SF segment's effect on
the PC membranes. It is possible that K+ ions compete with the amphi-
philic L622-K638 hERG segment for an interaction with the phospholipid
polar headgroups, most likely with the carbonyl groups where K+ ions
are known to bind [57]. Altogether, our results suggest that the SF could
interact with the membrane via its aromatic residue but that this inter-
action is most likely hindered by the local K+ ions concentration.
Discovering new drug binding sites on hERG channels is fundamen-
tal when attempting to elucidate its role in the ALQTS. Our 1H NMR
translational diffusion measurements (Table 2) evaluated the potential
binding of ﬁve LQTS-prone drugs to individual SF segments. The results
show that promethazine has the highest afﬁnity for the L622-K638 seg-
ment with an association close to 40%. The SF segment could therefore
be an additional binding site for this antihistamine drug which also
binds Tyr652 and Phe656 on the S6 helix according to electrophysiologi-
cal studies [62]. Previous published work has demonstrated that muta-
tions to Thr623, Ser624 and Val625 on the SF aswell as on Phe656 of the S6
reduced the channel block by bepridil [29]. However, our translational
diffusion experiments only reveal a low afﬁnity (9%) of this drug for
the hERG's SF, suggesting that this channel's segment is not a primary
target for bepridil. 1H NMR translational diffusion experiments recently
performed by our group had also showed a low afﬁnity of this drug for
the hERG's extracellular S5-P linker [11]. We can hypothesize that
bepridil needs the pore geometry to efﬁciently bind to sites in the chan-
nel pore, or to more hydrophobic amino acid residues found on the
transmembrane S6 helix.
Cetirizine, diphenhydramine and ﬂuvoxamine also display a very
weak binding afﬁnity (14% or below) for the L622-K638 hERG segment
as shown in Table 2. 1H NMR translational diffusion measurements
reported 13% and 9% association of cetirizine and diphenhydramine,
respectively, to the hERG's S5-P linker [11], yet the hERG blocking
ability of cetirizine and its derivative diphenhydramine is still a mat-
ter of debate [68–70]. As for ﬂuvoxamine, it has been hypothesized
that this antidepressant could bind to either the cytoplasmic or extra-
cellular side of the channel and not to the pore cavity contrarily to
most LQTS-active drugs [35,61]. Altogether, our results indicate that
cetirizine, diphenhydramine and ﬂuvoxamine are unlikely to bind
the hERG's SF.
The hERG channel has a large pore cavity (12 Å) and, as described
in the Introduction, has a particular kinetics [1,48]. It is in the open
state for a longer time during the heart repolarization. According to
computational studies, the SF would be ﬂexible and change conforma-
tion during the functioning of K+-selective channels [20]. Therefore
we believe that the drugs' afﬁnity for individual SF segments mea-
sured in this work gives a valuable insight on their potential to bind
this segment in the actual hERG tetrameric organization. Combination
of long-lasting open state and most likely mobile SF units certainly fa-
vors the access of drugs to sites in the pore domain and on the SF units.
It should be noted that the L622-K638 hERG segment studied here com-
prises the SVGFG motif but also the amino acid residues connecting it
to S6. It is thus also possible that drugs bind this short linker.
When probing the afﬁnity of the ﬁve drugs for the model
cardiomyocyte membranes, our 1H NMR translational diffusion mea-
surements revealed a 96 to 100% association that is not affected by the
presence of the peptide (Table 2). The STD measurements (Fig. 4) indi-
cate that all hERG-active drugs tested prefer the polar side of the bilayer.
Bepridil and promethazine –which have the highest log P – seem to be
located close to the glycerol region whereas cetirizine and ﬂuvoxamine
are nearer to the choline headgroups. Diphenhydramine –which shows
the strongest effect on the 31P and 2H NMR spectra of the DMPC mem-
branes – would be particularly close to the lipids considering the low
STD values measured. In all cases, the phospholipid mobility would be
reduced by the presence of the drugswith noperturbation of the hydro-
phobic core, as suggested by the 31P and 2H SS-NMR spectra (Fig. 5). The
formation of smaller objects could also be induced by the drugs which,
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even disrupt the membrane and lead to the formation of smaller faster
tumbling vesicles. Overall, our NMR study demonstrates that the tested
drugs can interact with phospholipid membranes. This is in agreement
with previous work reporting the interaction of promethazine with
dipalmitoylPC (DPPC) membranes [60]. Also, a study by van Balen et
al. [71] proposed that the zwitterionic form of cetirizine – such as at
the pH used in our study – interacts by weak electrostatic surface inter-
actions with the polar headgroups of egg PC liposomes. Bepridil,
cetirizine and diphenhydramine were also known to bind to DMPC/
DHPC bicelles although they were found to slightly increase the phos-
pholipid acyl chains ordering near the polar headgroup [11] as opposed
to what is observed here with DMPC MLVs. The effect on bicelles was
very small and could also have been ascribed to reduced bicelle
wobbling.
The presence of cardiotoxic drugs in the membrane environment
modiﬁes the SF segment's association with the phospholipid bilayer,
as evidenced in Table 2, and this would be correlated to the afﬁnity
of the SF segment for each individual drug. More speciﬁcally,
promethazine has the highest (37%) afﬁnity for the SF segment, and
its membrane association is increased by 18% in the presence of this
antihistamine. Correspondingly, no change in the membrane associa-
tion of the SF segment is seen in the presence of ﬂuvoxamine which
has the lowest afﬁnity (3%) for this hERG moiety. As for intermediate
cases such as diphenhydramine and cetirizine which respectively
have an 8% and 14% afﬁnity for hERG's L622-K638 segment, their effect
on its membrane association is either null (cetirizine) or within (8%
for diphenydramine) the error limit of the method. This observation
suggests that a fraction of the SF segment would interact directly
with the lipid bilayer while another population would interact with
membrane-bound drugs. This “attracting” effect of the drugs, howev-
er, appears to be not applicable to bepridil. Despite a 9% afﬁnity for
the SF segment comparable to that of diphenhydramine, bepridil mol-
ecules bound to the bilayer reduce its membrane association by 14%.
This effect could possibly be due to a competition for interaction sites
in the lipid bilayer. Altogether, our results suggest that the association
of hERG's L622-K638 segment with the membrane in the presence
of drugs depends on factors such as the drug/segment, segment/
membrane and drug/membrane afﬁnity as well as the nature of the
molecular interaction and the presence of K+ ions. They also propose
that modiﬁcation of the membrane afﬁnity of hERG moieties due to
drug attraction or interference could affect the channel function — a
mechanism that needs more investigation.
Besides channel obstruction, it is also possible that drug–membrane
interactions can be indirectly involved in the ALQTS mechanism by
facilitating the access of drugs to intracellular targets on the hERG chan-
nel, similarly to enkephalins thatwould need themembrane interaction
prior to receptor binding [72]. As discussed in our previous study on
hERG's S5-P linker [11], the interaction of drugs with the membrane
could modify its local properties and perturb the channel functioning.
The mechanical properties of biomembranes imparted by the nature
of its lipid content are determinant for the structure and function of
membrane proteins such as ion channels, as reviewed elsewhere [73].
Perturbation of the membrane protein annular shell by drugs is
suspected to play a role in the action mechanism of anesthetics and
toxins [74–76].
5. Conclusion
Our combined solution and SS-NMR study of the hERG's L622-K638
segment contributed to shed light on the SF structure and functioning
as well as on its role in the ALQTS. We have showed that this SF seg-
ment is unstructured in an aqueous environment on the NMR time-
scale, with and without K+ ions, in agreement with its expected
ﬂexibility required during the different channel conductive states.
Moreover, the SF segment was shown to have a potential to interactwith the phospholipid membrane surface — an interaction that
would be hindered by the surrounding K+ ions in its milieu. Our
results indicate that the hERG's SF could be a binding site for
promethazine and, thus, play a role in the ALQTS reported for this an-
tihistamine. However, it would not be a primary target for bepridil,
cetirizine, diphenhydramine and ﬂuvoxamine. Finally, the high afﬁn-
ity of the cardiotoxic drugs for the lipid membrane as well as their ef-
fect on the membrane interaction of hERG's SF segment supports the
possibility of an indirect role of the membrane in the ALQTS.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbamem.2013.02.012.
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